🟡 60/100

Review before taking

  • Fish Oil: 4320mg is 1.4× the Tolerable Upper Intake Level (3000mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Fish Oil: 4320mg is 1.4× the Tolerable Upper Intake Level (3000mg)

The safety score is low because the amount of fish oil in this supplement exceeds the recommended maximum daily intake level.

Label Data

1 Softgel(s) Serving Size
15 Servings
Fat/Fatty Acid Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

4320 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 3000 mg) 📚 388 studies (Tier A: 18, B: 204)
This product: 4320mg UL 3000mg

Other Ingredients

D-Alpha-Tocopherol

Label Claims — Verification

Nutrient
All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Super DHA 1860 mg per day Recommended Use: Adults. Take one or two softgels, two or three times a day, at mealtimes.

⚠️ Warnings & Precautions

Precautions: Contains fish derivatives.

Do not exceed the recommended daily dose. This product is a nutritional supplement and should not replace a varied, balanced diet.

Keep out of childrens' reach.

As with any nutritional supplement, you should consult a health professional before taking this product if you are pregnant, breastfeeding or have a health problem.

🧪 Formulation Notes

Docosahexaenoic Acid Ecosapentaenoic Acid

Each softgel contains 310 mg of DHA and 43 mg of EPA.

Additional Information

Store away from direct light, heat and humidity.

Product Details

UPC / SKU 5 453003 821403
DSLD Entry Date 2023-05-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand SuperSmart
DSLD ID 285259
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →